Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site. - Test2 - elhamkhani - TriplyDB

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

http://www.wikidata.org/entity/Q34323300

about

Melatonin in Chronic Pain Syndromes Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis 2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway Binding interaction of a novel fluorophore with serum albumins: steady state fluorescence perturbation and molecular modeling analysis.Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.Association of MMP7 -181A→G Promoter Polymorphism with Gastric Cancer Risk: INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB).Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition.Potent anticancer activity of cystine-based dipeptides and their interaction with serum albumins.Melatonin as a treatment for gastrointestinal cancer: a review.Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain-mediated C/EBPβ and NFκB cleavage.Melatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms.Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells.Circadian control of pain and neuroinflammation.Melatonin inhibits autophagy and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis.Melatonin causes regression of endometriotic implants in rats by modulating angiogenesis, tissue levels of antioxidants and matrix metalloproteinases.Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.

P2860

Q26764959-B688B0E7-D379-48CD-9266-99B3E0E422FD Q26823494-06A48388-64B4-4A4C-BEAF-64A68764F17C Q28489107-132E9089-086C-4964-AE81-C9EFB672A280 Q30379918-8069AC0C-7F94-407C-86B0-438155B17D85 Q33624824-102DF68E-7A55-4BF2-95C9-754E0E2F9AC1 Q34161592-0959F8D8-FF4D-4CD9-804F-D5EE857F85E5 Q34439817-71B7DB4A-BCF5-46D2-AABF-0A9C412305B2 Q35860763-0322129F-EB6E-4C33-BAAC-E61859713369 Q36010456-3E29C6F9-CD20-4773-9719-B462DD882E9B Q36922973-043E4446-825A-4CB0-9631-5C7C865746A6 Q38370739-33AA295C-E09B-4713-8F82-AE92C1B4A2B9 Q38823916-5E89A795-020D-4023-8317-F5F1F92DFF69 Q39346336-C9E9A8C4-FB37-4269-84D4-A4B723AFDE97 Q40996633-9A46E003-5E1C-4438-B937-A64FD2F6547F Q41036251-AC239804-7EB9-431B-A0BF-3243F961BC4F Q47103306-9E966EB2-3A37-4864-8F52-0F162F40FA4D Q48136577-A5EEA2A1-7C20-44DD-A48D-7B312769BF81 Q50445895-48474966-96D8-432E-90C6-3AC010E7837C Q51068219-0B829857-BBA7-43B2-AACA-18D0C148B190 Q54224159-F10BFD47-ED0E-44B8-8E61-A0685EF2E8C5

P2860

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

http://www.wikidata.org/entity/Q34323300

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@ast

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@en

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@nl

type

label

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@ast

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@en

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@nl

prefLabel

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@ast

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@en

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@nl

P1433

Q34323300-1635B026-F634-4A50-90AC-AF7F67FA5B2A

P1476

Q34323300-0E2DF16A-0311-4E29-837D-A7993168BC16

P2093

Q34323300-4159EB0B-3F40-4D3F-82C5-5CB177FF2614

Q34323300-871CA929-84A6-46EF-BF9E-138F88B67709

Q34323300-B902E5E0-67D2-4FB6-AE33-855A9A22AD11

Q34323300-C3B6504A-ECC8-435B-97C5-8C63DC521CF7

P2860

Q34323300-05AD0836-8557-4423-AA2F-B5BBD4D84D55

Q34323300-072C0B38-B8AC-4EEE-B47E-492E98E5CAED

Q34323300-0BC86BB6-5BB7-4C62-B909-4FA68C967937

Q34323300-1440A754-AB5F-4849-BA5E-8D69E0AC281E

Q34323300-2697B5F6-0F36-4246-A73C-6EABE8303D1A

Q34323300-2DEFF2CB-442A-4628-B56B-F7A169F7F9E0

Q34323300-2F138888-D53E-47FE-8BDB-427CB6AA8741

Q34323300-39544E64-9C62-4CFA-B54C-D59B6E405906

Q34323300-3B8DBED7-0CB0-44AC-BFE5-B95E19588F3E

Q34323300-480EA229-EEF7-453C-B28A-8E6A8F991751

P304

Q34323300-34DD219C-D24E-494D-93B6-ABD9D75F9C33

P31

Q34323300-7856FB42-3A31-4E3A-A502-D8BD368E0A8B

P356

Q34323300-ADF1C47A-599E-49F5-AB9B-1640B65841BD

P433

Q34323300-75C126A4-3B0F-45E7-A8AC-3CB7126B82B5

P478

Q34323300-4AC2C037-F204-4A73-BD52-42DBB88BC757

P50

Q34323300-1CC204E6-F0F0-44B3-BCCA-FA1A89F1B1CD

P577

Q34323300-6A452955-9F69-40E2-A221-A2442B29C09D

P5875

Q34323300-5480B05C-8C68-41F9-8040-3E4F9467E25F

P698

Q34323300-3511A813-A658-4A05-BD01-55C022F112D5

P921

Q34323300-C6AFB8FB-0E62-44C6-8012-36594D5C30E9

P356

P1433

Journal of Pineal Research

P1476

Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.

@en

P2093

Deep Sankar Rudra

http://www.w3.org/2001/XMLSchema#string

Nakul Chandra Maiti

http://www.w3.org/2001/XMLSchema#string

Russel J Reiter

http://www.w3.org/2001/XMLSchema#string

Snehasikta Swarnakar

http://www.w3.org/2001/XMLSchema#string

P2860

A Review of the Multiple Actions of Melatonin on the Immune System

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity

Matrix metalloproteinases

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

Matrix metalloproteinase-9 and autoimmune diseases

P304

398-405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JPI.12034

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234127552

http://www.w3.org/2001/XMLSchema#string

P698

23330737

http://www.w3.org/2001/XMLSchema#string

P921